Atlas Trials

A Study to Evaluate Albumin and Immunoglobulin in Alzheimer's Disease

Clinical trial NCT01561053 · COMPLETED

Trial details

NCT number
NCT01561053
Sponsor
Instituto Grifols, S.A.
Status
COMPLETED
Phase
Phase 2, Phase 3
Study type
INTERVENTIONAL
Alzheimer's Disease
Start date
2012-04-19
Primary completion
2018-03-06
Enrollment
347

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.